Tardi Med Sciences Llc Timber Pharmaceuticals, Inc. (TMBR) insider trading activity
Tardi Med Sciences LLC is > 10% Shareholder of Timber Pharmaceuticals, Inc.. Currently has a direct ownership of 3.51 Million shares of TMBR, which is worth approximately $0. The most recent transaction as insider was on Sep 02, 2021, when has been sold 225,000 shares (Common Stock, par value $0.001 per share) at a price of $0.94 per share, resulting in proceeds of $211,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
3.51M
0%
3M change
0%
12M change
Total Value Held
$0
TardiMed Sciences LLC Transaction History
Also insider at
TSL
Tardi Med Sciences LLC
> 10% Shareholder
Tarrytown, NY